The risks of reversed chirality: Study highlights dangers of mirror organisms

The study on mirror bacteria highlights risks of immune evasion and ecological threats, calling for collaboration to ensure safe synthetic biology practices.

Sarepta, Arrowhead Pharmaceuticals partner to advance RNA-based drugs in rare diseases

Sarepta Therapeutics said Tuesday that it will pay Arrowhead Pharmaceuticals $500 million in cash for a series of experimental RNA-based drugs to treat rare diseases

November 26, 2024

HHS says it is working to stop the climate crisis. But it’s really just climate washing

The U.S. Department of Health and Human Services has stated it will do all that it can to mitigate the health care industry’s greenhouse gas

August 15, 2024

One doctor’s quest to help people with hearing loss enjoy ‘all the richness’ of music

As a child in Jacksonville, Fla., Alex Chern built string instruments out of office supplies and tuned them, stretching rubber bands taut to change their

October 18, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.